A. Apfel

BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial

G. Shapiro, P. Ravindran, J. Diamond, 2022, Cancers.

Initial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer.

D. Jackson, S. Chasalow, J. Diamond, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A stability analysis of sparse K-means

Abraham Apfel, A. Apfel, 2017 .